Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00762333 · ClinicalTrials.gov registry record
Circulating Markers for Ischemic Heart Disease
A clinical trial of Myocardial Infarction and Congestive Heart Failure, sponsored by UConn Health.
- Recruiting
- Registry status
- 550
- Enrollment target
- 1
- Study location
NCT00762333: Recruiting study of Myocardial Infarction and Congestive Heart Failure, sponsored by UConn Health.
NCT00762333 is a study of Myocardial Infarction and Congestive Heart Failure that is actively recruiting participants, run by UConn Health. The registered enrollment target is 550 participants, below the 4,673-participant average among 64 other Myocardial Infarction trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00762333, a study of Myocardial Infarction and Congestive Heart Failure, is actively recruiting participants, sponsored by UConn Health.
- RECRUITING
- Registry status
- 550 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research is to determine if two proteins in the blood are increased during acute myocardial infarction and whether their levels are higher in those who develop heart failure than those who do not. These two proteins are produced and potentially released when the heart muscle is damaged. They may then be released into the blood and be detected by standard method in the research laboratory. At this time, detection of an increase in these proteins in the blood is not known to be associated with any disease or myocardial infarction.
Conditions Studied
Study Locations (1)
Connecticut
- University of Connecticut Health Center - Farmington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 550 participants |
| Start Date | 2007-06 |
| Est. Completion | 2027-03 |
What NCT00762333 shows while recruiting
NCT00762333 is an observational study that tracks outcomes without assigning an intervention. The registered 550 participants enrollment target is mid-sized for trials with a published cap, below the 4,673-participant average among 64 other Myocardial Infarction trials with a reported enrollment target (88% lower).
The record links to 3 conditions, with Myocardial Infarction appearing as the primary indexed condition, and to 0 interventions.
NCT00762333 reports a single indexed study location in Connecticut.
Frequently Asked Questions
What is clinical trial NCT00762333 about?
NCT00762333 is a clinical study titled "Circulating Markers for Ischemic Heart Disease". The purpose of this research is to determine if two proteins in the blood are increased during acute myocardial infarction and whether their levels are higher in those who develop heart failure than those who do not. These two proteins are produced and potentially released when the heart muscle is d...
What is the current status of trial NCT00762333?
This trial is currently recruiting. The enrollment target is 550 participants. The study started on 2007-06. Estimated completion is 2027-03.
What conditions does trial NCT00762333 study?
This clinical trial studies the following conditions: Myocardial Infarction, Congestive Heart Failure, Ischemia.
Who is sponsoring clinical trial NCT00762333?
This trial is sponsored by UConn Health, which has 178 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00762333 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Myocardial Infarction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00762333's enrollment target sits among peer trials
550 24th of 64 higher than 41 of 64 other Myocardial Infarction trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Myocardial Infarction trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Integration of Telemedicine and Home-Based Cardiac Rehabilitation: Feasibility, Efficacy, and Adherence
RECRUITING
-
MCNAIR Study: coMparative effeCtiveness of iN-person and teleheAlth cardIac Rehabilitation
RECRUITING · NA
-
Women's Heart Attack Research Program: Stress Ancillary Study
RECRUITING · NA
-
AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor
RECRUITING
-
Heart Attack Research Program: Platelet Sub-Study (HARP)
RECRUITING
-
Identification of Genomic Predictors of Adverse Events After Cardiac Surgery
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01852448 · 550 participants
Genetics of Insulin and Incretins in Cystic Fibrosis
- NCT02995252 · 550 participants
The HOPE Study: Characterizing Patients With Hepatitis B and C
- NCT03474913 · 550 participants
Upright MRI for Prostate Cancer Screening
- NCT04761120 · 550 participants
Annuloplasty Rings and Band Post-Market Clinical Follow-Up Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia